Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
HK Stock MarketDetailed Quotes
02196 FOSUN PHARMA
- 14.840
- +0.040+0.27%
Market Closed Apr 25 16:08 CST
39.51BMarket Cap13.20P/E (TTM)
15.100High14.700Low3.46MVolume14.720Open14.800Pre Close51.68MTurnover0.64%Turnover Ratio13.20P/E (Static)2.66BShares19.50052wk High0.77P/B8.05BFloat Cap11.52052wk Low0.30Dividend TTM542.73MShs Float80.580Historical High0.301Dividend LFY2.70%Amplitude5.897Historical Low14.935Avg Price500Lot Size2.03%Div YieldTTM2.03%Div Yield LFY
FOSUN PHARMA News
FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: Overseas regulatory announcement - Announcement regarding the resignation of senior management personnel.
FOSUN PHARMA: Notification Letter to Shareholders - Notice of Publication of 2024 Environmental, Social and Governance (ESG) and Sustainability Report
FOSUN PHARMA: 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) AND SUSTAINABILITY REPORT
FOSUN PHARMA: Notification Letter and Request Form to Non-registered Shareholders - Notice of Publication of Annual Report 2024
FOSUN PHARMA: Notification Letter and Request Form to Registered Shareholders - Notice of Publication of Annual Report 2024
FOSUN PHARMA: ANNUAL REPORT 2024
FOSUN PHARMA: Overseas regulatory announcement - A notice on the Shareholding of controlling subsidiary equity.
FOSUN PHARMA: Overseas regulatory announcement - Notification regarding the progress of A-share buybacks.
FOSUN PHARMA: DATE OF BOARD MEETING
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: CONNECTED TRANSACTION - DISPOSAL OF A PORTION OF EQUITY INTEREST IN SUBSIDIARY
FOSUN PHARMA: Overseas regulatory announcement - Announcement regarding the sale of Assets and related transactions and new daily related transactions.
FOSUN PHARMA: Overseas regulatory announcement - Legal opinion letter from Guohao Law Firm (Shanghai) regarding the repurchase and cancellation of part of the restricted A-shares stock incentive plan of Shanghai FOSUN PHARMA (Group) Co., Ltd. for 2022.
FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: Overseas regulatory announcement - Announcement regarding the repurchase and cancellation of certain restricted A-shares that have not had their restrictions lifted.
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement of Resolutions of the Second Meeting (Extraordinary Meeting) of the Ninth Supervisory Board in 2025.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs